-
1.
公开(公告)号:US20070129539A1
公开(公告)日:2007-06-07
申请号:US11562327
申请日:2006-11-21
Applicant: Lin Zhi , E. Kallel , Dean Phillips
Inventor: Lin Zhi , E. Kallel , Dean Phillips
IPC: C07D231/38
CPC classification number: C07D231/38 , C07D231/46 , C07D403/12
Abstract: Disclosed herein are novel diazenyl pyrazole compounds and related compounds. Also disclosed herein are methods of using these compounds for the treatment of diseases and conditions associated with modulating a thrombopoietin activity.
Abstract translation: 本文公开的是新的二唑基吡唑化合物和相关化合物。 本文还公开了使用这些化合物来治疗与调节血小板生成素活性相关的疾病和病症的方法。
-
2.
公开(公告)号:US20060116417A1
公开(公告)日:2006-06-01
申请号:US11256572
申请日:2005-10-21
Applicant: Jyun-Hung Chen , E. Kallel , Thomas Lau , Matthew McNeill , Todd Miller , Bao Nguyen , Richard Penuliar , Dean Phillips , Daniel Ruppar , Lin Zhi , Jackline Dalgard
Inventor: Jyun-Hung Chen , E. Kallel , Thomas Lau , Matthew McNeill , Todd Miller , Bao Nguyen , Richard Penuliar , Dean Phillips , Daniel Ruppar , Lin Zhi , Jackline Dalgard
IPC: A61K31/404 , C07D209/36
CPC classification number: C07D471/04 , C07D209/40 , C07D217/24 , C07D239/04 , C07D239/60 , C07D277/04 , C07D277/54 , C07D401/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D417/12
Abstract: Disclosed herein are compounds of Formula (I), (II), and (III) pharmaceutical compositions comprising the same, methods of modulating the activity a thrombopoietin receptor using the same, methods of identifying compounds as thrombopoietin receptor modulators, and methods of treating disease by administering a compound of the invention to a patient in need thereof.
Abstract translation: 本文公开了式(I),(II)和(III)的化合物,其包含其的药物组合物,使用其调节血小板生成素受体的活性的方法,鉴定化合物作为血小板生成素受体调节剂的方法,以及治疗疾病的方法 通过向有需要的患者施用本发明的化合物。
-
公开(公告)号:US20070254875A1
公开(公告)日:2007-11-01
申请号:US10590119
申请日:2005-03-11
Applicant: Lin Zhi , Robert Higuchi , E. Kallel , Cornelis Van Oeveren , Jyun-Hung Chen , Daniel Ruppar , Bijan Pedram , Thomas Stevens Lau , T. Miller
Inventor: Lin Zhi , Robert Higuchi , E. Kallel , Cornelis Van Oeveren , Jyun-Hung Chen , Daniel Ruppar , Bijan Pedram , Thomas Stevens Lau , T. Miller
IPC: A61K31/538 , A61K31/40 , A61K31/404 , A61P1/14 , A61P15/10 , A61P15/18 , A61P17/14 , A61P25/24 , A61P35/00 , C07D207/26 , C07D207/16 , C07D207/12 , C07D207/09 , C07D207/08 , C07C255/58 , C07C211/52 , A61P7/00 , A61P5/24 , C12Q1/18 , C12N5/08 , C07D295/06 , C07D265/36 , C07D215/36 , C07D215/18 , C07D211/60 , C07D211/22 , C07D209/12 , C07D209/08 , A61P29/00 , A61P21/00 , A61P17/10 , A61P15/16 , A61P15/08 , A61K31/451 , A61K31/473
CPC classification number: C07C211/52 , C07C205/55 , C07C255/58 , C07C2601/08 , C07D207/08 , C07D207/09 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/27 , C07D207/46 , C07D209/04 , C07D209/08 , C07D209/12 , C07D211/22 , C07D211/56 , C07D211/60 , C07D215/04 , C07D215/18 , C07D265/36 , C07D295/073 , C07F7/1804 , G01N2333/723
Abstract: Provided herein are compounds having a structure selected from among Formula (I), Formula (II), Formula (III), Formula (IV), Formula (V) and Formula (VI) that are androgen receptor modulators and/or androgen receptor binding agents. Also disclosed are methods of making and using such compounds, including, but not limited to, using such compounds for treating various conditions.
Abstract translation: 本文提供具有选自式(I),式(II),式(III),式(IV),式(V)和式(VI))的结构的化合物,其是雄激素受体调节剂和/或雄激素受体结合 代理商 还公开了制备和使用这些化合物的方法,包括但不限于使用这些化合物来处理各种条件。
-
4.
公开(公告)号:US20080103190A1
公开(公告)日:2008-05-01
申请号:US11963115
申请日:2007-12-21
Applicant: Jyun-Hung Chen , E. Kallel , Thomas Lau , Matthew McNeill , Todd Miller , Bao Nguyen , Richard Penuliar , Dean Phillips , Daniel Ruppar , Lin Zhi , Jackline Dalgard
Inventor: Jyun-Hung Chen , E. Kallel , Thomas Lau , Matthew McNeill , Todd Miller , Bao Nguyen , Richard Penuliar , Dean Phillips , Daniel Ruppar , Lin Zhi , Jackline Dalgard
IPC: A61K31/404 , A61P7/00 , C07D209/30 , C12N5/00 , G01N33/53
CPC classification number: C07D471/04 , C07D209/40 , C07D217/24 , C07D239/04 , C07D239/60 , C07D277/04 , C07D277/54 , C07D401/04 , C07D403/12 , C07D405/04 , C07D409/04 , C07D417/12
Abstract: Disclosed herein are compounds, pharmaceutical compositions comprising the same, methods of modulating the activity a thrombopoietin receptor using the same, methods of identifying compounds as thrombopoietin receptor modulators, and methods of treating disease by administering a compound of the invention to a patient in need thereof.
Abstract translation: 本文公开了化合物,包含其的药物组合物,使用其调节血小板生成素受体的活性的方法,鉴定化合物作为血小板生成素受体调节剂的方法,以及通过向有需要的患者施用本发明化合物来治疗疾病的方法 。
-
-
-